Rachael Cecka
Physician Assistant · Charlotte, NCNPI 1366050791
Payments from drug & device makers
Across 415 payments — averaging $26.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$2K
- Novartis$725
- Merck$706
- Actelion Pharmaceuticals US, Inc.$704
- Cardiovascular Systems Inc.$650
- Johnson & Johnson$519
- plus $6K from 29 others
What the payments were for
- Consulting fees$6006%
- Travel & lodging$3353%
- Food & beverage$9,80490%
- Education$981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 56 | $1,638 |
| Novartis | 32 | $725 |
| Merck | 31 | $706 |
| Actelion Pharmaceuticals US, Inc. | 24 | $704 |
| Cardiovascular Systems Inc. | 9 | $650 |
| Johnson & Johnson | 27 | $519 |
| Scpharmaceuticals Inc. | 14 | $510 |
| Amgen | 24 | $475 |
| AstraZeneca | 24 | $455 |
| Abbott | 13 | $444 |
| Boehringer Ingelheim | 17 | $444 |
| Sanofi-aventis U.S. LLC | 16 | $398 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $378 |
| Heartflow, Inc. | 4 | $336 |
| E.r. Squibb & Sons, L.L.C. | 21 | $306 |
| Novo Nordisk | 14 | $277 |
| United Therapeutics Corporation | 9 | $266 |
| Esperion Therapeutics, Inc. | 7 | $229 |
| Abiomed | 9 | $226 |
| Pfizer | 10 | $184 |
| Merz North America, Inc. | 1 | $150 |
| Lexicon Pharmaceuticals, Inc. | 7 | $135 |
| Kiniksa Pharmaceuticals International, PLC | 6 | $128 |
| Medtronic | 1 | $100 |
| Cvrx, Inc. | 3 | $88 |
| Amarin Pharma, Inc. | 3 | $68 |
| Boston Scientific | 3 | $50 |
| Kestra Medical Technology Services, Inc. | 3 | $48 |
| Edwards Lifesciences | 2 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Atricure, Inc. | 1 | $26 |
| Medicure Pharma Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Diamondback Peripheral$681
- Adempas$600
- FFRct$259
- XEOMIN$150
- MitraClip$144
- FUROSCIX$130
- NEXLIZET$125
- NEXLETOL$125
- VERQUVO$116
- AURORA EV-ICD MRI SURESCAN$100
How this compares
$10,837 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AdempasRiociguat | 21 | $230,176 |
| EntrestoSacubitril/Valsartan | 69 | $108,137 |
| XareltoRivaroxaban | 76 | $82,210 |
| EliquisApixaban | 52 | $47,085 |
| FarxigaDapagliflozin Propanediol | 42 | $34,575 |
| JardianceEmpagliflozin | 30 | $33,652 |
| MultaqDronedarone Hcl | 15 | $30,121 |
| Repatha SureclickEvolocumab | 18 | $18,600 |
| OzempicSemaglutide | 13 | $15,951 |
| Ranolazine ErRanolazine | 14 | $2,373 |
| Nebivolol Hcl | 16 | $1,110 |
| Metoprolol Succinate | 91 | $540 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 35 | $498 |
| Atorvastatin Calcium | 67 | $484 |
| Spironolactone | 53 | $425 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BayerAdempas | $1,638 | $230,17621 claims |
| NovartisEntresto | $725 | $108,13769 claims |
| Johnson & JohnsonXarelto | $519 | $82,21076 claims |
| PfizerEliquis | $184 | $47,08552 claims |
| AstraZenecaFarxiga | $455 | $34,57542 claims |
| Boehringer IngelheimJardiance | $444 | $33,65230 claims |
| Sanofi-aventis U.S. LLCMultaq | $398 | $30,12115 claims |
| Novo NordiskOzempic | $277 | $15,95113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Charlotte
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Kristin CabedaCharlotte$135K
- Meghan EmigCharlotte$124K
- Juleidy TurnipseedCharlotte$84K
- Erin SiceloffCharlotte$50K
- Ronald RodriguezCharlotte$31K
- Lamiaa TolbaCharlotte$29K
- Sanaya GandhiCharlotte$29K
- Jacqueline LeyrerCharlotte$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.